vs

Side-by-side financial comparison of Kymera Therapeutics, Inc. (KYMR) and La Rosa Holdings Corp. (LRHC). Click either name above to swap in a different company.

La Rosa Holdings Corp. is the larger business by last-quarter revenue ($20.2M vs $11.5M, roughly 1.8× Kymera Therapeutics, Inc.). La Rosa Holdings Corp. runs the higher net margin — -27.4% vs -667.6%, a 640.2% gap on every dollar of revenue. On growth, La Rosa Holdings Corp. posted the faster year-over-year revenue change (3.2% vs -55.3%). Over the past eight quarters, La Rosa Holdings Corp.'s revenue compounded faster (72.5% CAGR vs 10.1%).

Kymera Therapeutics is a clinical-stage biopharmaceutical company specialized in developing innovative targeted protein degradation therapies. It advances a diversified pipeline of drug candidates targeting previously undruggable proteins to address unmet medical needs in oncology, autoimmune and inflammatory diseases worldwide.

V. La Rosa and Sons Macaroni Company was founded in 1914 by Vincenzo La Rosa, a Sicilian immigrant. The company eventually became one of the largest regional brands in the United States producing over 40 varieties of pasta.

KYMR vs LRHC — Head-to-Head

Bigger by revenue
LRHC
LRHC
1.8× larger
LRHC
$20.2M
$11.5M
KYMR
Growing faster (revenue YoY)
LRHC
LRHC
+58.4% gap
LRHC
3.2%
-55.3%
KYMR
Higher net margin
LRHC
LRHC
640.2% more per $
LRHC
-27.4%
-667.6%
KYMR
Faster 2-yr revenue CAGR
LRHC
LRHC
Annualised
LRHC
72.5%
10.1%
KYMR

Income Statement — Q2 FY2025 vs Q3 FY2025

Metric
KYMR
KYMR
LRHC
LRHC
Revenue
$11.5M
$20.2M
Net Profit
$-76.6M
$-5.5M
Gross Margin
8.4%
Operating Margin
-736.8%
-24.7%
Net Margin
-667.6%
-27.4%
Revenue YoY
-55.3%
3.2%
Net Profit YoY
-82.1%
-125.7%
EPS (diluted)
$-0.95
$-5.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KYMR
KYMR
LRHC
LRHC
Q3 25
$20.2M
Q2 25
$11.5M
$23.2M
Q1 25
$22.1M
$17.5M
Q4 24
$7.4M
$17.7M
Q3 24
$19.6M
Q2 24
$25.6M
$19.1M
Q1 24
$10.3M
$13.1M
Q4 23
$47.9M
Net Profit
KYMR
KYMR
LRHC
LRHC
Q3 25
$-5.5M
Q2 25
$-76.6M
$78.4M
Q1 25
$-65.6M
$-95.7M
Q4 24
$-70.8M
$-5.1M
Q3 24
$-2.5M
Q2 24
$-42.1M
$-2.3M
Q1 24
$-48.6M
$-4.6M
Q4 23
$-14.4M
Gross Margin
KYMR
KYMR
LRHC
LRHC
Q3 25
8.4%
Q2 25
8.0%
Q1 25
8.8%
Q4 24
8.9%
Q3 24
8.3%
Q2 24
8.3%
Q1 24
8.9%
Q4 23
Operating Margin
KYMR
KYMR
LRHC
LRHC
Q3 25
-24.7%
Q2 25
-736.8%
-10.6%
Q1 25
-336.8%
-26.7%
Q4 24
-1092.2%
-17.1%
Q3 24
-8.9%
Q2 24
-198.5%
-9.7%
Q1 24
-562.2%
-35.0%
Q4 23
-40.3%
Net Margin
KYMR
KYMR
LRHC
LRHC
Q3 25
-27.4%
Q2 25
-667.6%
337.8%
Q1 25
-296.7%
-546.5%
Q4 24
-956.9%
-28.7%
Q3 24
-12.5%
Q2 24
-164.0%
-12.2%
Q1 24
-472.0%
-35.1%
Q4 23
-30.0%
EPS (diluted)
KYMR
KYMR
LRHC
LRHC
Q3 25
$-5.44
Q2 25
$-0.95
$15.25
Q1 25
$-0.82
$-5.86
Q4 24
$-0.89
$28.54
Q3 24
$-16.49
Q2 24
$-0.58
$-12.49
Q1 24
$-0.69
$-0.35
Q4 23
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KYMR
KYMR
LRHC
LRHC
Cash + ST InvestmentsLiquidity on hand
$335.8M
$4.0M
Total DebtLower is stronger
$642.8K
Stockholders' EquityBook value
$971.5M
$1.6M
Total Assets
$1.1B
$21.7M
Debt / EquityLower = less leverage
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KYMR
KYMR
LRHC
LRHC
Q3 25
$4.0M
Q2 25
$335.8M
$5.1M
Q1 25
$90.0M
$2.9M
Q4 24
$120.3M
$1.4M
Q3 24
$1.8M
Q2 24
$67.6M
$1.6M
Q1 24
$93.5M
$1.1M
Q4 23
$110.0M
Total Debt
KYMR
KYMR
LRHC
LRHC
Q3 25
$642.8K
Q2 25
$644.3K
Q1 25
$645.9K
Q4 24
$647.6K
Q3 24
$649.2K
Q2 24
$650.8K
Q1 24
$652.4K
Q4 23
Stockholders' Equity
KYMR
KYMR
LRHC
LRHC
Q3 25
$1.6M
Q2 25
$971.5M
$3.4M
Q1 25
$786.2M
$-87.5M
Q4 24
$835.6M
$2.6M
Q3 24
$5.0M
Q2 24
$684.9M
$4.7M
Q1 24
$711.2M
$5.6M
Q4 23
$395.0M
Total Assets
KYMR
KYMR
LRHC
LRHC
Q3 25
$21.7M
Q2 25
$1.1B
$22.9M
Q1 25
$918.3M
$21.0M
Q4 24
$978.0M
$19.4M
Q3 24
$19.7M
Q2 24
$826.0M
$18.7M
Q1 24
$868.3M
$16.3M
Q4 23
$575.8M
Debt / Equity
KYMR
KYMR
LRHC
LRHC
Q3 25
0.41×
Q2 25
0.19×
Q1 25
Q4 24
0.25×
Q3 24
0.13×
Q2 24
0.14×
Q1 24
0.12×
Q4 23

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KYMR
KYMR
LRHC
LRHC
Operating Cash FlowLast quarter
$-59.9M
$-1.3M
Free Cash FlowOCF − Capex
$-60.6M
FCF MarginFCF / Revenue
-527.9%
Capex IntensityCapex / Revenue
6.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-250.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KYMR
KYMR
LRHC
LRHC
Q3 25
$-1.3M
Q2 25
$-59.9M
$-1.4M
Q1 25
$-79.2M
$-3.5M
Q4 24
$-61.8M
$-1.1M
Q3 24
$-591.6K
Q2 24
$-42.9M
$-803.1K
Q1 24
$-39.6M
$-538.3K
Q4 23
$8.0M
Free Cash Flow
KYMR
KYMR
LRHC
LRHC
Q3 25
Q2 25
$-60.6M
Q1 25
$-79.6M
Q4 24
$-62.7M
Q3 24
Q2 24
$-47.6M
Q1 24
$-47.0M
Q4 23
$-3.6M
FCF Margin
KYMR
KYMR
LRHC
LRHC
Q3 25
Q2 25
-527.9%
Q1 25
-360.3%
Q4 24
-848.3%
Q3 24
Q2 24
-185.7%
Q1 24
-456.8%
Q4 23
-7.5%
Capex Intensity
KYMR
KYMR
LRHC
LRHC
Q3 25
Q2 25
6.1%
Q1 25
2.1%
Q4 24
12.7%
Q3 24
Q2 24
18.3%
Q1 24
72.0%
Q4 23
24.3%
Cash Conversion
KYMR
KYMR
LRHC
LRHC
Q3 25
Q2 25
-0.02×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KYMR
KYMR

Segment breakdown not available.

LRHC
LRHC

Real Estate Residential Brokerage Services$16.8M83%
Transferred Over Time$3.5M17%

Related Comparisons